5. Nishino T. Dyspnoea: underlying
mechanisms and treatment.Br J Anaesth.
2011;106:463-474.
6. N e d e rJ ,B e r t o nD ,M ü l l e rP ,e ta l .
Ventilatory inef ﬁciency and
exertional dyspnea in early chronic
obstructive pulmonary disease.Ann
Am Thorac Soc . 2017;14(suppl_1):
S22-S29 .
7. Gruenberger JB, Vietri J, Keininger DL,
Mahler DA. Greater dyspnea is associated
with lower health- related quality of life
among European patients with COPD.Int
J Chron Obstruct Pulmon Dis. 2017;12:
937-944.
8. Preteroti M, Whitmore GA,
Vandemheen KL, et al. Population-based
case-ﬁnding to identify subjects with
undiagnosed asthma or COPD.Eur Respir
J. 2020;55:2000024.
9. Huynh C, Whitmore GA,
Vandemheen KL, et al. Derivation and
validation of the UCAP-Q case-ﬁnding
questionnaire to detect undiagnosed
asthma and COPD.Eur Respir J.
2022;60(3):2103243.
10. Shin B, Cole SL, Park SJ, et al. A new
symptom-based questionnaire for
predicting the presence of asthma.
J Investig Allergol Clin Immunol. 2010;20:
27-34.
11. Price DB, Tinkelman DG, Nordyke RJ,
et al. Scoring system and clinical
application of COPD diagnostic
questionnaires. Chest. 2006;129:
1531-1539.
12. Price DB, Tinkelman DG, Halbert RJ,
et al. Symptom-based questionnaire for
identifying COPD in smokers.
Respiration. 2006;73:285-295.
13. Jones PW, Harding G, Berry P, et al.
Development and ﬁrst validation of the
COPD Assessment Test.Eur Respir J.
2009;34:648-654.
14. Jones PW. Quality of life measurement for
patients with diseases of the airways.
Thorax. 1991;46:676-682.
15. Jones PW, Quirk FH, Baveystock CM. The
St George’s Respiratory Questionnaire.
Respir Med. 1991;85:25-31.
16. Jones PW. St George’s Respiratory
Questionnaire: MCID. J Chronic Obstr
Pulm Dis. 2005;2:75-79.
17. Global Initiative for Asthma. Global
strategy for asthma management and
prevention. Global Initiative for Asthma
website. Accessed July 30, 2023.https://
ginasthma.org/wp-content/uploads/2023/
07/GINA-2023-Full-report-23_07_06-
WMS.pdf
18. Global Initiative for Chronic Obstructive
Lung Disease. Global strategy for the
diagnosis, management, and prevention of
chronic obstructive pulmonary disease.
Global Initiative for Chronic Obstructive
Lung Disease website. Accessed July 30,
2023. https://goldcopd.org/wp-content/
uploads/2023/03/GOLD-2023-ver-1.3-17
Feb2023_WMV.pdf
19. Magner KMA, Cherian M, Whitmore GA,
et al. Assessment of preserved ratio
impaired spirometry (PRISm) using pre
and post bronchodilator spirometry in a
randomly-sampled symptomatic cohort.
Am J Resp Crit Care Med. 2023;208(10):
1129-1131.
20. Hanania NA, O’Donnell DE. Activity-
related dyspnea in chronic obstructive
pulmonary disease: physical and
psychological consequences, unmet
needs, and future directions. Int J
Chron Obstruct Pulmon Dis . 2019;14:
1127-1138.
21. Reilly Associates. WPAI scoring. Reilly
Associates website. Accessed May 1, 2024.
http://www.reillyassociates.net/wpai_
scoring.html
22. Carlsen HK, Haga SL, Olsson D, et al.
Birch pollen, air pollution and their
interactive effects on airway symptoms
and peak expiratoryﬂow in allergic
asthma during pollen season– a panel
study in Northern and Southern Sweden.
Environ Health. 2022;21:63.
23. Ekström M, Johannessen A,
Abramson MJ, et al. Breathlessness across
generations: results from the RHINESSA
generation study. Thorax. 2022;77(2):
172-177.
24. Ziegler B, Fernandes AK, Sanches PR,
Konzen GL, Dalcin Pde T. Variability of
dyspnea perception in healthy subjects
assessed through inspiratory resistive
loading. J Bras Pneumol. 2015;41(2):
143-150.
25. Ekström M, Bornefalk H, Sköld M, et al.
Validation of the Swedish
Multidimensional Dyspnea Proﬁle (MDP)
in outpatients with cardiorespiratory
disease. BMJ Open Respir Res. 2019;6:
e000381.
26. Yorke J, Russell AM, Swigris J, et al.
Assessment of dyspnea in asthma:
validation of The Dyspnea-12.J Asthma.
2011;48(6):602-608.
27. Boulet LP, Boulay ME, Cote A, et al.
Airway inﬂammation and
hyperresponsiveness in subjects with